CD8A and ovarian cancer: Peritoneal immune suppression (PMN) in ovarian cancer is characterized by the dysfunction of dendritic cells (DCs), a reduction in CD8+ T-cell numbers, an increase in myeloid-derived suppressor cells (MDSCs), and alterations in immune cell phenotypes (11, 12).